Menu
Thanks to doctors, scientists, technologists, researchers, and practitioners who helped pioneer the field of cellular therapy our team and research partner sites are developing cellular implant technology to treat degenerative diseases of the musculoskeletal, dermal, and organ systems.
With cellular therapy, a patient’s own cells can be used to repair and regenerate tissues or control pain and inflammation. Cells are harvested from either fat (adipose) or bone marrow and separated and concentrated to create a therapeutic cellular implant, delivered using a needle injection.
Our tissue processing platform enables point-of-care therapy in a single disposable device. Physicians can use the SVF-2 to extract and process adipose tissue in real time using proven scientific methods, controls and reagents. The SVF-2 provides scalable cell processing for hospitals, medical practices and other surgical or clinical settings.
Investigations of degenerative musculoskeletal diseases
Pilot investigations of non-healing wounds of the dermal layers
Pilot investigations of fibrotic conditions of the lung and liver
Adipose tissue holds the critical cells necessary for cellular medicine, but, in the past, tissue processing has been inaccessible to most health care providers due to the high costs and expertise required.
Now, GID BIO technology allows physicians to extract cells from adipose tissue at point of care with a single-use, disposable device.
We want to improve patient outcomes and their healing processes through advancements in cellular treatments and technologies
We aim to bring access to cellular therapy to everyone who needs it. Using the SVF-2 is a simple procedure for physicians and support staff.
The aim of the GID BIO SVF-2 device is to provide patients and providers with consistent, reproducible, high quality results with every single use.
Using the GID BIO solution, providers can offer patients a walk-in and walk-out procedure for tissue harvest and cellular implant.
Our clinical pipeline features targeted therapeutic applications and clinical development in three primary therapeutic domains.
Curious about GID BIO? Contact us – we are ready to answer all your questions.